Topics

GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study

19:00 EST 7 Nov 2019 | NEJM

npj Digital Medicine, Published online: 08 November 2019; doi:10.1038/s41746-019-0182-1

GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study

Original Article: GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study

NEXT ARTICLE

More From BioPortfolio on "GPS mobility as a digital biomarker of negative symptoms in schizophrenia: a case control study"

Quick Search

Relevant Topic

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...